MADEDDU, Giordano
 Distribuzione geografica
Continente #
NA - Nord America 4.482
EU - Europa 3.581
AS - Asia 1.029
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 16
AF - Africa 12
Totale 9.164
Nazione #
US - Stati Uniti d'America 4.452
IT - Italia 1.466
UA - Ucraina 975
CN - Cina 774
DE - Germania 371
SE - Svezia 177
FR - Francia 157
FI - Finlandia 144
SG - Singapore 135
GB - Regno Unito 93
CZ - Repubblica Ceca 56
KR - Corea 30
RO - Romania 27
TR - Turchia 27
CA - Canada 25
BE - Belgio 24
AU - Australia 23
IN - India 17
EU - Europa 14
RU - Federazione Russa 14
BR - Brasile 13
PL - Polonia 13
IR - Iran 12
CH - Svizzera 9
NL - Olanda 8
ES - Italia 7
IE - Irlanda 7
JP - Giappone 6
SA - Arabia Saudita 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
BG - Bulgaria 5
LU - Lussemburgo 5
PT - Portogallo 5
HK - Hong Kong 4
HU - Ungheria 4
MD - Moldavia 4
MX - Messico 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
IL - Israele 3
NG - Nigeria 3
CL - Cile 2
MA - Marocco 2
MK - Macedonia 2
MZ - Mozambico 2
PK - Pakistan 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
BT - Bhutan 1
EC - Ecuador 1
ML - Mali 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SL - Sierra Leone 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
ZM - Zambia 1
Totale 9.164
Città #
Chandler 1.265
Jacksonville 577
Princeton 396
New York 232
Nanjing 192
Dearborn 190
Wilmington 155
Sassari 141
Rome 114
Ann Arbor 106
Boardman 95
Singapore 87
Nanchang 82
Shenyang 70
Beijing 68
Milan 63
Ashburn 62
Brno 56
Woodbridge 47
Tianjin 46
Hebei 43
Cagliari 39
Changsha 39
Jinan 35
Naples 30
Seoul 28
Jiaxing 26
Ningbo 26
Norwalk 25
Brussels 24
Zhengzhou 24
Andover 23
Turin 23
Helsinki 21
Kunming 21
Munich 20
Toronto 20
Falls Church 19
Guangzhou 19
Mountain View 19
Taizhou 19
Izmir 18
San Francisco 18
Florence 15
Hangzhou 15
Auburn Hills 13
Changchun 12
Sydney 12
Bologna 11
Lanzhou 11
Genoa 10
Leawood 10
Los Angeles 10
Palermo 10
Ardabil 9
Brescia 9
Lappeenranta 9
San Mateo 9
Washington 9
Edinburgh 8
Gonnosfanàdiga 8
Verona 8
Alghero 7
Bari 7
Horia 7
Napoli 7
Dublin 6
Ravenna 6
Augusta 5
Canberra 5
Città Di Castello 5
Cosenza 5
Frankfurt am Main 5
Haikou 5
Hefei 5
Houston 5
Monza 5
São Bernardo do Campo 5
Catania 4
Cernusco sul Naviglio 4
Chisinau 4
Dallas 4
Iesi 4
London 4
Luxembourg 4
Novara 4
Padova 4
Paris 4
Pescara 4
Redwood City 4
Riyadh 4
Salzano 4
Seattle 4
Tappahannock 4
Torino 4
Trento 4
Venice 4
Amsterdam 3
Bolzano 3
Brunete 3
Totale 4.996
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.152
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 110
Meningite linfomatosa in un paziente con linfoma plasmoblastico del cavo orale HIV-relato: ruolo della citarabina liposomiale. 88
PARVOVIRUS B19 E POLIMIALGIA REUMATICA: THE BUTTERFLY EFFECT 88
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 86
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 85
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 83
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 81
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 75
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 74
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 70
Utilizzo di EVG/COBI/FTC/TDF in una paziente con viremia elevata e cirrosi HCV-correlata 68
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 66
Trends in the European HIV/AIDS epidemic: a perspective from Italy 65
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 64
Kidney disease in HIV-infected patients. 62
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 62
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 62
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 62
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 61
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 61
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 60
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 59
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 59
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 58
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 57
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 57
The HIV treatment and care cascade in Italy: successes and disparities 56
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 56
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 55
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 55
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 55
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 55
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. 54
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 54
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. 54
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences 53
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study 53
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 52
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 52
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 52
The monitoring and the management of adverse events: a new challenge in the treatment of HIV infection: results from a cohort study. 52
Drug-resistant disseminated polyclonal Mycobacterium avium complex in a patient with AIDS: a case report and review of the literature 52
EFFICACIA A TOLLERABILITÀ DELLA DUAL THERAPY RALTEGRAVIR+DARUNAVIR/RITONAVIR NELLA PRATICA CLINICA 52
Rhino-maxillary and orbital mucormycosis in a patient with acute myeloid leukaemia:a successful surgery and antifungal therapy combined approach 52
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study. 51
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. 51
Tache Noire in a Patient with Acute Q Fever 51
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 51
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 51
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 51
COBI: I DATI DI EFFICACIA IN CO-FORMULAZIONE CON ELVITEGRAVIR 50
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 50
Myalgia and phosphokinase elevations in the HAART era: focus on Raltegravir. 50
Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s 50
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 50
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 50
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting. 50
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 49
Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors 48
Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma. 48
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy. 48
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 48
Low High-density Lipoprotein Cholesterol (HDL) is Associated with the Risk of Non-AIDS Defining Malignancies 47
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 47
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 46
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 46
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 46
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project). 46
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 45
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 45
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 45
CAIDE risk score predicts atherosclerosis and vascular events in HIV patients. Preliminary data from the Italian multicentre cohort of CARdiovascular and late-life Dementia risk in HIV (CARDH) Study 45
Bacterial community-acquired pneumonia in HIV-infected patients 45
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 44
QuantiFERON TB Gold: a new method for latent tuberculosis infection 44
The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients 44
FATTORI ASSOCIATI A RIDUZIONE DELLE PRESTAZIONI MNESICHE IN UNA COORTE POLICENTRICA DI PAZIENTI CON INFEZIONE DA HIV. DATI PRELIMINARI DEL COGNITIVE SUBSTUDY: PROGETTO “ALESSITIMIA E RISCHIO CARDIOVASCOLARE IN HIV” 44
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 43
HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART 43
Hepatic echinococcosis: clinical and therapeutic aspects. 43
Adverse skin reactions in course of combined antiretroviral therapy 43
Prevalence of Respiratory Symptoms and Screening for Chronic Obstructive Pulmonary Disease: Results from an Italian Multicenter Study 43
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 43
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 43
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice. 42
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 42
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. 42
Body fat distribution changes and highly active antiretroviral therapy (HAART): a clinical study in HIV patients 42
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study. 40
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 40
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 40
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 40
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 40
Rickettsia monacensis as Cause of Mediterranean Spotted Fever-like Illness, Italy 39
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study 39
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 39
A case of vasculitis-like skin eruption associated with COVID-19 39
SLAM project - Second-level diagnostic assessment: Multidisciplinary approach to HIV Patients 39
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: The HIV-HY study 39
Totale 6.418
Categoria #
all - tutte 46.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.554 320 11 124 11 159 176 287 29 181 69 167 20
2020/20211.498 169 13 212 12 179 67 187 52 271 224 76 36
2021/20221.109 130 29 26 26 26 32 40 63 83 72 143 439
2022/20232.522 239 209 68 414 208 404 37 274 402 47 130 90
2023/20241.209 139 72 56 40 293 114 35 79 17 48 101 215
2024/2025116 116 0 0 0 0 0 0 0 0 0 0 0
Totale 9.645